Pfizer Comparative Analysis

You can use this module to analyze advantages of Pfizer technical and fundamental indicators over its peers. Please use the box above to enter up to 8 concurrent symbols you would like to analyze. Use comma (,) to separate each symbol. With this comparative module your can estimate the relative strength of Pfizer Inc against its competitors. Additionally take a look at Pfizer Correlation with its peers.

    
 Better Than Average     
    
 Worse Than Peers or Benchmark    View Performance Chart
Pfizer Inc
Johnson Johnson
Novartis AG
Merck Co Inc
GlaxoSmithKline plc
BristolMyers Squibb
Eli Lilly and
AstraZeneca PLC
Market Performance
(Over the last 30 days)
 0 of 100 0 of 100 4 of 100 0 of 100 0 of 100 0 of 100 4 of 100 2 of 100
Probability Of Bankruptcy
(Chance of Financial Distress)
36 %8 %16 %16 %40 %7 %14 %36 %
Beta
Operating Margin
Profit Margin
Current Ratio
Price to Book
Price to Earning
Return On Asset
Shares Owned by Insiders
Gross Profit
Price to Earnings To Growth
Return On Equity
One Year Low
Cash Flow from Operations
Shares Owned by Institutions
Shares Outstanding
Number of Shares Shorted
Working Capital
Debt to Equity
Cash per Share
Total Asset
Market Capitalization
Current Liabilities
Book Value Per Share
Short Ratio
Retained Earnings
EBITDA
Net Income
Total Debt
Price to Sales
Cash and Equivalents
Revenue
Z Score
Current Asset
Earnings Per Share
One Year High
Current Valuation
Day Median Price
Rate Of Daily Change
Accumulation Distribution
Market Facilitation Index
Day Typical Price
Price Action Indicator
Daily Balance Of Power
Expected Short fall
Treynor Ratio
Coefficient Of Variation
Variance
Market Risk Adjusted Performance
Downside Deviation
Jensen Alpha
Information Ratio
Skewness
Mean Deviation
Semi Variance
Maximum Drawdown
Potential Upside
Risk Adjusted Performance
Kurtosis
Standard Deviation
Semi Deviation
Sortino Ratio
Total Risk Alpha
Downside Variance
Value At Risk
(0.62) / 1.81%

 33.64 

 Pfizer
(1.03) / 0.87%

 117.78 

 Johnson Johnson
(0.75) / 0.92%

 80.73 

 Novartis AG
(0.81) / 1.29%

 62.15 

 Merck
(0.46) / 1.06%

 42.96 

 GlaxoSmithKline plc
(1.00) / 1.77%

 55.48 

 BristolMyers Squibb
(1.64) / 2.02%

 79.52 

 Eli Lilly
(0.42) / 1.24%

 33.55 

 AstraZeneca PLC